Novel Drug Boosts Anti-VEGF Effects in AMD

CHICAGO (MedPage Today) -- Adding an investigational agent on top of anti-angiogenesis drugs may improve outcomes in wet age-related macular degeneration (AMD), researchers said here.

Full Story →